Crispr Pioneer Launches Startup to Make Tailored Gene-Editing Treatments

Gene-Editing Startup Aims to Revolutionize Treatment for Rare Diseases with Crispr Technology

A new startup, Aurora Therapeutics, co-founded by Nobel Prize-winning scientist Jennifer Doudna, is working on developing tailored gene-editing treatments for patients with rare diseases. The company plans to use a new FDA regulatory pathway that allows the approval of personalized therapies based on data from just a handful of patients.

Currently, the development and approval process for new drugs requires testing in hundreds or thousands of patients, making it challenging to recruit participants for rare disease trials. However, the new FDA pathway provides a way for these types of treatments to be approved when a large, randomized trial isn't possible.

Aurora Therapeutics aims to tackle a metabolic disorder called phenylketonuria (PKU), which is screened for at birth and can lead to toxic levels of phenylalanine in the blood if left untreated. Patients with PKU must follow a highly restrictive low-protein diet, and without early treatment and monitoring, it can hinder brain development and impair cognitive functions.

The company's strategy involves using base editing, a more precise form of Crispr gene editing, to create several versions of a PKU therapy that address different mutations. This approach will allow Aurora to treat many patients with the disease with less regulatory red tape compared to traditional approaches.

Aurora's goal is to provide treatment options for those who currently have limited or no access to effective therapies. The company is already making progress, having successfully treated a sick infant named KJ with a bespoke gene-editing therapy that corrected his specific genetic mutation.

While Crispr technology has yet to fully live up to its transformative potential, experts believe that the field is turning a corner as the technology matures. With continued advancements and refinements, it's likely that Crispr-based treatments will become more widespread in the coming years.

The Innovative Genomics Institute, which Doudna established in 2015, will continue to create bespoke gene-editing therapies for children with rare diseases, while a trial at the Children's Hospital of Philadelphia and Penn Medicine will test the same type of gene editor used in KJ's therapy in a group of similar disorders.
 
๐Ÿค I'm loving the progress being made on Crispr tech ๐Ÿ’ก! It's amazing to see a startup like Aurora Therapeutics taking the lead on developing tailored treatments for rare diseases ๐ŸŒŸ. The fact that they're using base editing and creating multiple versions of therapy to tackle different mutations is super promising ๐Ÿ“ˆ. And I'm so grateful to hear about KJ, the little guy who got treated with a bespoke gene-editing therapy ๐Ÿ’–. It's giving me all the feels knowing that there are people like Jennifer Doudna working hard to make a difference in the lives of patients with rare diseases โค๏ธ. Fingers crossed that this tech will become more widespread and accessible to those who need it most! ๐Ÿคž
 
I think it's really awesome that Aurora Therapeutics is giving patients with rare diseases like PKU a chance to get personalized treatment ๐ŸŒŸ. Traditional trials just aren't feasible for these cases, so this new pathway by the FDA is a huge step forward ๐Ÿ‘. And I'm loving the fact that they're using base editing with Crispr gene editing - it's so precise and targeted ๐Ÿงฌ. The fact that KJ got to live without having to follow such a restrictive diet because of his bespoke therapy is just amazing โค๏ธ. It's not going to fix everything overnight, but I'm optimistic about where this tech is headed ๐Ÿ‘Š
 
Wow ๐Ÿ’ฅ๐Ÿ”ฌ Aurora Therapeutics is taking a huge step forward in treating rare diseases! Using Crispr technology to create tailored treatments for patients with genetic mutations is a game-changer ๐Ÿš€. It's interesting that they're using base editing, a more precise form of gene editing, to address different mutations ๐Ÿ‘. The fact that they've already treated an infant named KJ with a bespoke therapy is mind-blowing ๐Ÿ˜ฎ. This technology has the potential to revolutionize treatment options for patients who have limited access to effective therapies ๐Ÿ’–.
 
This gene editing thing is like the whole healthcare system overhaul debate we had like 5 years ago ๐Ÿค”. Remember how we were talking about access to treatment for chronic diseases? Well, Aurora Therapeutics is basically saying that with Crispr tech, they can tailor treatments for individual patients with rare diseases. It's like having a personalized pill vs a one-size-fits-all approach ๐Ÿ’Š.

But here's the thing, what happens when this technology becomes more widespread? Are we gonna see private companies like Aurora making decisions on who gets treated and at what cost? And what about the regulatory pathways they're using? Is it just a matter of big pharma influencing the FDA? ๐Ÿค‘

And let's not forget about the ethics of gene editing. Are we playing God here? Shouldn't we be focusing on preventative measures rather than trying to fix individual genetic mutations? ๐Ÿ’ก It's like, what's next? Gene editing for cosmetic purposes? ๐Ÿ˜ณ
 
I'm so stoked about this new startup Aurora Therapeutics! ๐Ÿคฉ They're trying to make a game-changer for people with rare diseases like PKU, which can be super tough to deal with. The fact that they're using Crispr gene editing tech is pretty cool, but I guess it's also super complicated? ๐Ÿ’ก

So, basically they're making personalized treatments for each person based on their specific genetic mutation, which sounds really clever. And the best part is that they can do this without needing to test tons of people like with regular meds. That's gonna make a huge difference for folks who need these treatments.

It's also awesome that they've already successfully treated a sick infant named KJ - talk about saving lives! ๐Ÿ’• And it's nice to see more research happening, especially at the Innovative Genomics Institute.

I just hope that Crispr tech becomes more accessible and affordable for everyone who needs it. That way we can make sure these treatments are available to those who need 'em most. ๐Ÿคž
 
๐Ÿ˜Š I can only imagine how tough it must be for those little angels to deal with PKU... their lives are literally put on hold because they need super strict diets that can be so hard to follow. ๐Ÿค• And the thing is, it's not just about them, but also their families who have to be so vigilant and restrictive too ๐Ÿ™. I'm glad Aurora Therapeutics is working towards creating more treatment options for them... and KJ's story is just amazing ๐Ÿ’–... a 3-year-old baby getting a bespoke gene-editing therapy to correct his genetic mutation? That's truly a miracle in itself โœจ!
 
Wow ๐Ÿคฏ Aurora Therapeutics is on fire ๐Ÿ’ฅ! I'm so interested ๐Ÿค” how they're using base editing with Crispr technology to create customized therapies for rare diseases. The fact that they've already treated an infant named KJ with a bespoke gene-editing therapy is mind-blowing ๐Ÿ’ก. It's like sci-fi, but it's real life! ๐Ÿ˜ฒ
 
just imagine being able to cure rare diseases like PKU ๐Ÿ’‰๐Ÿ’– the new gene-editing startup Aurora Therapeutics is on a mission to make that happen with their Crispr technology ๐ŸŽฏ and it's so cool that they're using a new FDA pathway that lets them approve therapies based on just a few patients ๐Ÿค this is the future of medicine we're talking about ๐Ÿ’ซ and I'm hyped that Jennifer Doudna is leading the charge ๐Ÿ‘ฉโ€๐Ÿ”ฌ she's a total genius! ๐Ÿ˜Ž
 
Wow! ๐Ÿคฏ I'm so down for any tech that helps make treatments for super rare diseases more accessible & effective ๐Ÿ’Š๐Ÿ‘จโ€โš•๏ธ Aurora Therapeutics is like, totally on the right track with this base editing thingy, and that it's gonna help people with PKU avoid all that crazy restrictive dieting ๐Ÿคช๐Ÿ’– The fact they're making progress in just a few months is super inspiring ๐Ÿ’ก
 
just saw this thread about Aurora Therapeutics... ๐Ÿค” so what I'm getting from this is that they're trying to use crisper tech to make treatments for super rare diseases and it's gonna be way more personalized? seems like a game changer for kids with PKU who have limited options now. hope they can scale up production and get these therapies out ASAP ๐Ÿ’Š
 
I donโ€™t usually comment but I think this is pretty cool ๐Ÿค”. A startup co-founded by Jennifer Doudna (sheโ€™s like, super smart ๐Ÿงฌ) is trying to make gene editing more accessible for people with rare diseases. Itโ€™s crazy that the FDA has created a new regulatory pathway just for personalized therapies - it's definitely making it easier for these types of treatments to get approved ๐Ÿ’ช.

The idea of tailored gene-editing therapies is mind-blowing, especially for kids like KJ who are struggling with PKU ๐Ÿค•. I donโ€™t know if we'll ever have enough money in the world to cover all these sick kids but this could definitely be a step in the right direction ๐Ÿ’ธ. Can you imagine being able to just edit out the bad genes instead of having to follow a super strict diet? Itโ€™s like science fiction come true ๐Ÿš€!
 
I'm so down ๐Ÿคฉ for this new approach! ๐Ÿ’ก Gene editing is the future ๐Ÿ‘. I've been following Aurora Therapeutics' progress, and it's amazing to see them making waves ๐Ÿ˜Š. The fact that they're using base editing with Crispr technology is a huge step forward ๐Ÿ’ช. It's like a game-changer ๐Ÿš€ for patients with rare diseases who have nowhere else to turn ๐Ÿค.

I'm loving the idea of personalized treatments based on data from just a handful of patients ๐Ÿ‘ฅ. It's all about making medicine more accessible and efficient ๐Ÿ’ป. And, can we talk about how cool it is that they've already successfully treated an infant? ๐Ÿคฑโ€โ™‚๏ธ It's like they're rewriting the rules ๐Ÿ“.

Of course, there are still challenges to overcome ๐Ÿ”ฌ, but I'm confident that Crispr technology will continue to evolve and improve ๐Ÿ’ก. The potential for treatment breakthroughs is vast ๐ŸŒ, and I couldn't be more excited ๐Ÿ‘€!
 
๐Ÿšจ๐Ÿ’” just found out that a new study shows that climate change is causing sea levels to rise 25% faster than projected, putting millions at risk of displacement ๐ŸŒŠ๐Ÿ˜ฑ and coastal communities in danger ๐Ÿ’ฅ meanwhile, global food production is expected to decrease by 2% due to droughts and warmer temps ๐Ÿด๐ŸŒช๏ธ sounds like the world isn't gonna be ready for the next big disaster ๐Ÿคฏ
 
๐Ÿค” so finally someone's working on making treatment for these super rare diseases that are basically impossible to get treatment for now ๐Ÿค• aurora therapeutics is like, the real MVP, especially with jen doudna at the helm ๐Ÿ’ช base editing might not be the most glamorous tech but hey, it's a start ๐ŸŒฑ and i'm actually kinda hyped about this progress ๐Ÿ‘€ hopefully they can make some of these treatments more accessible to people who need them ๐Ÿคž
 
๐ŸŒŸ I think it's super cool that there's finally some movement on gene editing treatments for rare diseases! It's like, we've been waiting forever to see some real progress on this front ๐Ÿ•ฐ๏ธ. The fact that Aurora Therapeutics is using base editing with Crispr technology is a huge step forward - it's so much more precise than traditional approaches ๐Ÿ’ก. And the best part? They're making treatment options available for people who currently have limited or no access to effective therapies ๐ŸŒˆ. It's like, finally! The Innovative Genomics Institute and the trials at the Children's Hospital of Philadelphia are super exciting too - it's amazing that we'll get to see these bespoke gene-editing therapies in action soon ๐Ÿ”ฌ. I just hope they keep pushing forward with this tech, because I truly believe it has the potential to revolutionize healthcare ๐Ÿ’–.
 
I'm low-key hyped about this new gene-editing startup! ๐Ÿ’– Aurora Therapeutics is like the superhero that rare disease patients have been waiting for, and it's awesome that Nobel Prize-winning scientist Jennifer Doudna is on board to help create tailored treatments using Crispr technology ๐Ÿงฌ. The fact that they're working with a new FDA pathway that lets them approve personalized therapies with just a few patient data points is game-changing ๐Ÿ’ฏ.

I'm all about that PKU life... like, who wouldn't want to eat pizza and play video games without worrying about having toxic levels of phenylalanine in their blood? ๐Ÿ•๐Ÿ‘พ It's crazy how some people have to follow these super restrictive diets just to survive. The fact that Aurora Therapeutics is working on bespoke gene-editing therapies that can address different mutations is like, total life-saving ๐Ÿ’ซ.

I'm also loving the progress they've made so far, like treating a sick infant named KJ with a bespoke gene-editing therapy that corrected his specific genetic mutation ๐Ÿคฏ. It's moments like these that remind me why scientists like Jennifer Doudna are doing what they're doing โ€“ to make a real difference in people's lives ๐Ÿ’•.

I'm not gonna lie, I know Crispr technology still has some growing pains, but it's cool to see experts saying that the field is turning a corner ๐Ÿš€. With continued advancements and refinements, it's likely that Crispr-based treatments will become more widespread soon ๐Ÿ’ช. Bring it on! ๐Ÿ‘Š
 
I'm like, totally stoked that there's progress being made on treating rare diseases with gene editing ๐Ÿคฉ but at the same time, I'm kinda skeptical about relying on just a handful of patients to test these new treatments... what if they don't accurately represent the larger patient population? And I mean, I know it's hard to find enough participants for trials, but shouldn't we be doing more to make those resources available? ๐Ÿค”

And another thing, using Crispr technology to create multiple versions of a therapy is pretty cool and all, but isn't that just gonna raise the price of treatment even further? I know it's meant to be more precise, but precision comes with a cost ๐Ÿ’ธ. And what about the long-term effects of gene editing on patients' health? We're still learning so much about this tech.

I'm also kinda worried that we're moving too fast without fully understanding the implications of using gene editing on human subjects... like, are we really prepared for the potential risks and side effects? ๐Ÿค• But I guess it's better to try and make progress than nothing at all ๐ŸŒŸ.
 
Ugh, I'm so sick of how slow this news is coming out ๐Ÿ™„. Can't we just have some real progress on gene editing already? It feels like every new breakthrough is met with "oh wait, there are still a ton of red tape and regulatory issues to deal with". Like, can't the FDA just chill for once? ๐Ÿ˜’ And what's up with having to test on only a handful of patients to get approval? That's not exactly a high bar to clear. I mean, how many more kids have to suffer because we're too lazy to do some actual research ๐Ÿคฆโ€โ™‚๏ธ. At least Aurora is trying to tackle something tangible like PKU, but it still feels like we're just scratching the surface here...
 
omg can u believe this?? ๐Ÿคฏ Aurora Therapeutics is literally changing lives with Crispr tech! ๐Ÿ’ก I mean, think about it, some patients are literally dying without access to effective treatments just cuz they have rare diseases ๐Ÿš‘. But now we got a startup that's trying to revolutionize the treatment game with personalized therapies ๐Ÿ‘. And the fact that it's using base editing, which is way more precise than traditional Crispr tech, is like whoa ๐Ÿคฉ! I'm so hyped about this development ๐Ÿ’ฅ. It's gonna be amazing to see how many lives are saved and improved cuz of these advancements ๐Ÿ’–. And kudos to Jennifer Doudna for co-founding this startup ๐Ÿ™Œ!
 
Back
Top